JPMorgan Chase & Co. Sells 79,669 Shares of SS&C Technologies Holdings, Inc. (NASDAQ:SSNC)

JPMorgan Chase & Co. reduced its position in shares of SS&C Technologies Holdings, Inc. (NASDAQ:SSNC - Free Report) by 13.8% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 496,310 shares of the technology company's stock after selling 79,669 shares during the quarter. JPMorgan Chase & Co. owned 0.20% of SS&C Technologies worth $36,831,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the business. Ashton Thomas Private Wealth LLC bought a new position in SS&C Technologies in the second quarter worth approximately $35,000. Benjamin Edwards Inc. raised its stake in shares of SS&C Technologies by 43.3% in the second quarter. Benjamin Edwards Inc. now owns 675 shares of the technology company's stock worth $42,000 after buying an additional 204 shares during the period. Capital Performance Advisors LLP purchased a new position in shares of SS&C Technologies during the 3rd quarter valued at about $68,000. Brooklyn Investment Group purchased a new stake in SS&C Technologies in the 3rd quarter worth approximately $73,000. Finally, Livforsakringsbolaget Skandia Omsesidigt bought a new stake in SS&C Technologies during the 3rd quarter worth approximately $89,000. Institutional investors own 96.95% of the company's stock.

SS&C Technologies Trading Down 0.2 %

NASDAQ SSNC traded down $0.12 during trading on Tuesday, hitting $75.58. The stock had a trading volume of 965,547 shares, compared to its average volume of 829,137. The stock has a market capitalization of $18.72 billion, a price-to-earnings ratio of 27.09 and a beta of 1.37. The stock has a 50 day simple moving average of $75.21 and a 200 day simple moving average of $72.60. SS&C Technologies Holdings, Inc. has a one year low of $59.18 and a one year high of $77.69. The company has a debt-to-equity ratio of 1.04, a quick ratio of 1.21 and a current ratio of 1.21.

SS&C Technologies (NASDAQ:SSNC - Get Free Report) last posted its quarterly earnings data on Thursday, October 24th. The technology company reported $1.29 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.26 by $0.03. SS&C Technologies had a return on equity of 17.33% and a net margin of 12.26%. The company had revenue of $1.47 billion during the quarter, compared to analysts' expectations of $1.44 billion. During the same quarter in the previous year, the business earned $1.04 EPS. SS&C Technologies's revenue was up 7.3% compared to the same quarter last year. Sell-side analysts predict that SS&C Technologies Holdings, Inc. will post 4.62 earnings per share for the current year.

SS&C Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, December 16th. Investors of record on Monday, December 2nd were issued a dividend of $0.25 per share. The ex-dividend date of this dividend was Monday, December 2nd. This represents a $1.00 dividend on an annualized basis and a yield of 1.32%. SS&C Technologies's payout ratio is 35.84%.

Insider Buying and Selling at SS&C Technologies

In other news, CEO William C. Stone sold 247,300 shares of the stock in a transaction on Thursday, December 5th. The stock was sold at an average price of $76.61, for a total transaction of $18,945,653.00. Following the transaction, the chief executive officer now owns 31,837,926 shares of the company's stock, valued at approximately $2,439,103,510.86. This represents a 0.77 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Jason Douglas White sold 69,000 shares of the firm's stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $77.07, for a total value of $5,317,830.00. Following the transaction, the senior vice president now owns 6,412 shares in the company, valued at approximately $494,172.84. This represents a 91.50 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 449,000 shares of company stock valued at $34,461,478 in the last three months. Company insiders own 15.40% of the company's stock.

Wall Street Analysts Forecast Growth

SSNC has been the subject of a number of analyst reports. DA Davidson reissued a "buy" rating and issued a $92.00 price objective on shares of SS&C Technologies in a research note on Thursday, October 10th. Royal Bank of Canada raised their price target on SS&C Technologies from $75.00 to $86.00 and gave the company an "outperform" rating in a report on Thursday, September 19th. StockNews.com downgraded SS&C Technologies from a "strong-buy" rating to a "buy" rating in a research note on Friday, November 15th. Needham & Company LLC reiterated a "buy" rating and set a $90.00 price objective on shares of SS&C Technologies in a research report on Friday, October 25th. Finally, Raymond James upped their target price on shares of SS&C Technologies from $79.00 to $85.00 and gave the company a "strong-buy" rating in a research report on Friday, October 25th. Two analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, SS&C Technologies presently has a consensus rating of "Moderate Buy" and a consensus target price of $77.75.

SS&C Technologies Profile

SS&C Technologies Holdings, Inc, together with its subsidiaries, provides software products and software-enabled services to financial services and healthcare industries. The company owns and operates technology stack across securities accounting; front-office functions, such as trading and modeling; middle-office functions comprising portfolio management and reporting; back-office functions, such as accounting, performance measurement, reconciliation, reporting, processing and clearing, and compliance and tax reporting; and healthcare solutions consisting of claims adjudication, benefit management, care management, and business intelligence solutions.